Xiaoyang Wu

• University of Chicago

Sources: reporter.nih.gov

• NIH Office of the Director

  R01, Development of epidermal progenitor cell-based therapy for regenerative medicine, R01OD023700, 2017–2021, Dec 11, 2020

• National Institute on Alcohol Abuse and Alcoholism

  R21, A Novel cutaneous gene therapy for combating alcohol use disorder, R21AA027172, 2018–2020, Aug 6, 2019

Sources: reporter.nih.gov